Aging and Health Research Briefs
Major Changes to Medicare Would Cut Costs but Also Squeeze Enrollment and Raise Spending for Seniors — 2013
Potential policy changes, such as raising the eligibility age of Medicare from 65 to 67, would save Medicare from $400 billion to $1.2 trillion between 2012 and 2036 but would also reduce the number of seniors enrolled.
Europe's demography: Are babies back? The recent recovery in EU period fertility due to older childbearing — 2011
An update to the RAND Europe 2004 study into the causes and consequences of low fertility in Europe analysing the latest data, reviewing recent literature, and examining the situation in Germany, Poland, Spain, Sweden and the UK in depth.
Results of a pilot program in RAND Health's Assessing Care of Vulnerable Elders-2 project indicate that quality indicators for dementia care are improved when primary care practices are coupled with links to local Alzheimer's Association chapters.
Describes the effects that prescription drug cost sharing has on drug spending, compliance with drug therapy, patient health, and overall health care costs.
Constrained Choice: Why Are Some Women and Men Able To Create and Maintain Healthy Lifestyles, While Others Are Not? — 2008
This fact sheet describes a model of constrained choice that explains how policy decisions at the family, work, community, and government levels can have unintended consequences that ultimately produce differences in men's and women's health.
This research brief summarizes the results of Assessing Care of Vulnerable Elderly (ACOVE)-2, which measured the quality of care delivered to a group of older adults, and describes a recent revision of the quality measures, known as ACOVE-3.
This fact sheet summarizes a study using the 1992-1999 Medicare Current Beneficiary Survey to investigate whether age directly affects health care costs, or whether life expectancy would produce more accurate estimates of future expenditures.
This research brief summarizes studies showing that medical innovations will improve health and extend life but will likely increase Medicare spending; eliminating obesity and better prevention could save Medicare money and improve health.
This research brief summarizes the results of a 2006 pilot survey of military retirees, providing information on retirees' enrollment in civilian health care plans and reliance on TRICARE, the Department of Defense-sponsored health insurance.
This research brief summarizes a study of how Medicare's prospective payment system (PPS) affected the quality of care for hospitalized Medicare patients.
This research brief summarizes findings on actions that can be taken to shape the U.S. health care system into one that helps Americans live out their final years comfortably, with a care system that is reliable, cost-effective, and sustainable.
This fact sheet describes the benefits of influenza vaccination for nursing home residents and staff.
A team of economists and physicians explored how changes in medical technology, disease, and disability would affect health care spending for the population age 65 and older.
RAND Health has collaborated with Pfizer, Inc. to create the first quality-of-care assessment system for older persons.
A team of experts from RAND Health has developed a system for measuring the quality of care delivered to the elderly and used the system to assess the quality of care given to a group of community-dwelling older adults who were members of a managed care plan.
This research brief summarizes RAND Health research on pharmacy compliance with California's prescription drug discount program for Medicare beneficiaries.
In a series of studies, we have assessed the cost and consequences of various approaches to providing coverage for these groups (children, employees in small businesses, substance abusers, the uninsured, and the near-elderly).
Anne Pebley and Laura Rudkin explore research results on the characteristics of grandchildren and grandparents in common households and identify a research agenda for this phenomenon.
Surprisingly little is known about how much the financial burden is, how much coverage might increase demand for prescription drugs, and how much such coverage might cost.